Rifamycin derivatives

Details for Australian Patent Application No. 2010240638 (hide)

Owner Alfa Wassermann S.p.A.

Inventors Viscomi, Giuseppe Claudio; Campana, Manuela; Folegatti, Mahena; Cannata, Vincenzo; Righi, Paolo; Rosini, Goffredo

Agent Lord and Company

Pub. Number AU-A-2010240638

PCT Pub. Number WO2010/122436

Priority MI2009A000653 20.04.09 IT

Filing date 18 March 2010

Wipo publication date 28 October 2010

International Classifications

C07D 493/20 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/437 (2006.01)

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 498/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/122436 Priority application(s): WO2010/122436

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010240641-A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates

2010240637-Pre-emptive fluid shifts to treat OSA